Last Updated: March 15, 2026
How Abgrat positions itself across medical and regulatory boundaries
This page explains Abgrat’s intended use, how it should be interpreted operationally, and why we describe the platform as informational support rather than a regulated medical device.
Intended use
Educational and informational support for reasoning and understanding.
Operational position
Human-led interpretation remains essential in any clinically meaningful setting.
Claims boundary
We avoid framing the product as an autonomous diagnosis or treatment system.
Intended Use
Abgrat is intended to support understanding, structured thinking, and information review. It is not intended to independently diagnose, treat, or prevent disease.
Positioning Logic
Our positioning depends on the product’s claims, user role, and operational context. Informational systems can still be useful without being framed as autonomous medical devices.
Human Oversight
Meaningful clinical use requires professional review, contextual judgment, and institutional governance.
- Qualified review
- Clear workflow boundaries
- Institutional policy alignment
Regulatory Evolution
Regulatory expectations can evolve. We may update product boundaries, disclosures, and operational controls as the platform matures.
FAQ
Does this page claim regulatory approval?
No. It explains positioning and intended use, not a blanket approval claim.
Can positioning change over time?
Yes. Product scope and disclosures may evolve with legal and operational requirements.
Contact
For organization-level questions about intended use or positioning, contact the Abgrat team.
contact@abgrat.com